Carcinogenesis · 2012 · 56 citations · 48 references
MedicineMolecular BiologyOncologyGene ExpressionMolecular OncologyOncogenesAndrogen Deprivation TherapyCancer Cell SignalingCancer ProgressionOncogene OverexpressionOncogenic Signaling PathwaysProstate CancerAndrogen Action In ProstateAndrogen Deprivation Therapy ResistanceMalignant ProgressionProstate Carcinogenesis
Myb, a cellular progenitor of v-Myb oncogenes, is amplified in prostate cancer and exhibits greater amplification frequency in hormone-refractory disease. Here, we have investigated the functional significance of Myb in prostate cancer. Our studies demonstrate Myb expression in all prostate cancer cell lines (LNCaP, C4-2, PC3 and DU145) examined, whereas it is negligibly expressed in normal/benign prostate epithelial cells (RWPE1 and RWPE2). Notably, Myb is significantly upregulated, both at transcript (>60-fold) and protein (>15-fold) levels, in castration-resistant (C4-2) cells as compared with androgen-dependent (LNCaP) prostate cancer cells of the same genotypic lineage. Using loss and gain of function approaches, we demonstrate that Myb promotes and sustains cell cycle progression and survival under androgen-supplemented and -deprived conditions, respectively, through induction of cyclins (A1, D1 and E1), Bcl-xL and Bcl2 and downregulation of p27 and Bax. Interestingly, Myb overexpression is also associated with enhanced prostate-specific antigen expression. Furthermore, our data show a role of Myb in enhanced motility and invasion and decreased homotypic interactions of prostate cancer cells. Myb overexpression is also associated with actin reorganization leading to the formation of filopodia-like cellular protrusions. Immunoblot analyses demonstrate gain of mesenchymal and loss of epithelial markers and vice versa, in Myb-overexpressing LNCaP and -silenced C4-2 cells, respectively, indicating a role of Myb in epithelial to mesenchymal transition. Altogether, our studies provide first experimental evidence for a functional role of Myb in growth and malignant behavior of prostate cancer cells and suggest a novel mechanism for castration resistance.
48
Ahmedin Jemal, Rebecca L. Siegel, Jiaquan Xu et al. · CA A Cancer Journal for Clinicians · 2010 · 12.6K citations · Full text
Horder, William Harnett · BMJ · 1941 · 1.3K citations · Full text
A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis
Michael L. Mucenski, Kersten McLain, Ann B. Kier et al. · Cell · 1991 · 1.1K citations
Marta Persson, Ywonne Andrén, Joachim Mark et al. · Proceedings of the National Academy of Sciences · 2009 · 781 citations · Full text